New shot aims to prevent clots without bleeding risk
Disease control
Completed
This early-stage trial tested a single injection of a new drug called SRSD107 in 48 healthy adults. The drug is designed to temporarily lower a clotting factor in the liver, potentially preventing dangerous blood clots with less bleeding risk than standard treatments. The main go…
Phase: PHASE1 • Sponsor: Sirius Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC